<DOC>
	<DOCNO>NCT02503761</DOCNO>
	<brief_summary>Newborns neonatal intensive care unit ( NICU ) , especially premature one immature organ system , frequently suffer nosocomial infection cause microorganisms resistant narrow-spectrum antibiotic like ampicillin gentamicin require introduction new agent wider spectrum activity . Meropenem activity wide variety Gram-negative Gram-positive bacteria . It well tolerate child neonate , include preterm baby , allow monotherapy instead combine therapy . Severe neonatal infection increase antibiotic resistance major problem affect morbidity mortality NICU . Few number new antibacterial agent enter clinic new agent multi-drug resistant Gram-negative bacteria unlikely available near future .</brief_summary>
	<brief_title>Bolus Versus Prolonged Infusion Meropenem Newborn With Late Onset Sepsis</brief_title>
	<detailed_description>More research exist antibiotic novel mechanisms action require combat increase resistance decrease development antibiotic . Efforts exert maximize antibiotic efficacy optimal dosing base pharmacodynamic pharmacokinetic property antibiotic . Meropenem administer mostly via 30-min infusion , data indicate rapid degradation reconstitution . Dose recommendation two pediatric study use Monte Carlo simulation emphasize 4-h infusion may need microorganism show increase minimal inhibitory concentration ( MICs ) , specifically , Pseudomonas aeruginosa . A prolonged-infusion strategy test neonate , although data suggest extremely small infusion volume may significantly affect drug amount actually deliver . Aim work : The objective study compare clinical bacteriological efficacy conventional intermittent dose meropenem prolonged infusion critically-ill neonate , proactive focus reduce ventilator day ventilate patient , length stay NICU , neonatal mortality .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Meropenem</mesh_term>
	<mesh_term>Thienamycins</mesh_term>
	<criteria>Neonates admit neonatal care unit ( NCU ) suffer late onset sepsis ( LOS ) admission NICU stay receive meropenem least four day Acute chronic renal failure Hypersensitivity allergy meropenem</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>4 Weeks</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>meropenem</keyword>
	<keyword>infusion</keyword>
	<keyword>late-onset sepsis</keyword>
	<keyword>newborn</keyword>
	<keyword>management</keyword>
</DOC>